VALERIA RICHARDS: Open Payments
NPI 1962828251 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 12 payments from 8 companies in 2025. Trend: 2023 $1,167 · 2024 $1,186 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Ardelyx, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
| Gilead Sciences, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| EVOKE PHARMA, INC. | 1 | $15 |
Products named: XIFAXAN, IBSRELA, MAVYRET, ENTYVIO, SKYRIZI, GIVLAARI, OCALIVA, GIMOTI.
Industry payments across VA — which companies pay providers there.
